(Press-News.org) Researchers at Vanderbilt University Medical Center have isolated human monoclonal antibodies against influenza B, a significant public health threat that disproportionately affects children, the elderly and other immunocompromised individuals.
Seasonal flu vaccines cover influenza B and the more common influenza A but do not stimulate the broadest possible range of immune responses against both viruses. In addition, people whose immune systems have been weakened by age or illness may not respond effectively to the flu shot.
Small-molecule drugs that block neuraminidase, a major surface glycoprotein of the influenza virus, can help treat early infection, but they provide limited benefit when the infection is more severe, and they are generally less effective in treating influenza B infections. Thus, another way to combat this virus is needed.
Reporting in the journal Immunity, the VUMC researchers describe how, from the bone marrow of an individual previously vaccinated against influenza, they isolated two groups of monoclonal antibodies that bound to distinct parts of the neuraminidase glycoprotein on the surface of influenza B.
One of the antibodies, FluB-400, broadly inhibited virus replication in laboratory cultures of human respiratory epithelial cells. It also protected against influenza B in animal models when given by injection or through the nostrils.
Intranasal antibody administration may be more effective and have fewer systemic side effects than more typical routes — intravenous infusion or intramuscular injection — in part because intranasal antibodies may “trap” the virus in the nasal mucus, thereby preventing infection of the underlying epithelial surface, the researchers suggested.
These findings support the development of FluB-400 for the prevention and treatment of influenza B and will help guide efforts to develop a universal influenza vaccine, they said.
“Antibodies increasingly have become an interesting medical tool to prevent or treat viral infections,” said the paper’s corresponding author, James Crowe Jr., MD. “We set out to find antibodies for the type B influenza virus, which continues to be a medical problem, and we were happy to find such especially powerful molecules in our search.”
Crowe, who holds the Ann Scott Carell Chair, is University Distinguished Professor of Pediatrics and director of the Vanderbilt Vaccine Center, which has isolated monoclonal antibodies against a host of viral infections, including COVID-19.
The paper’s first author, Rachael Wolters, DVM, PhD, is a former graduate student in the Crowe lab. Other VUMC co-authors are Elaine Chen, PhD, Ty Sornberger, Luke Myers, Laura Handal, Taylor Engdahl, Nurgen Kose, Lauren Williamson, PhD, Buddy Creech, MD, and Katherine Gibson-Corley, DVM, PhD.
This study was supported in part by National Institutes of Health grants T32AI112541, K01OD036063 and U01AI150739, NIH-HHS contracts 75N93019C00074 and 75N93019C00073, and the Collaborative Influenza Vaccine Innovation Centers program of the National Institute of Allergy and Infectious Diseases.
Illustration: A 3D rendering shows one of the isolated antibodies, FluB-393, (blue) binding to the neuraminidase surface glycoprotein (red) of the influenza type B virus to prevent infection.
(illustration by Elad Binshtein, PhD, and Anthony Czelusniak)
END
Antibodies may aid effort to fight influenza B: Study
2024-05-31
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
ASCO: Novel CAR T therapy and shorter targeted therapy durations show promise for patients with leukemia
2024-05-31
Novel CAR T cell therapy obe-cel yields strong remission rates in adults with relapsed or refractory B-ALL (Abstract 6504)
The novel anti-CD19 autologous chimeric antigen receptor (CAR) T cell therapy obecabtagene autoleucel (obe-cel) achieved durable remissions in 40% of patients with relapsed or refractory B-ALL without a subsequent stem cell transplant (SCT), according to results from the Phase Ib/II FELIX clinical trial presented today by Elias Jabbour, M.D., professor of Leukemia.
At a median follow-up of 21.5 months, these patients were in ongoing remission ...
Synthetic plugs offer alternative to total knee replacements
2024-05-31
Osteochondral defects (OCDs) can cause damage to cartilage and underlying bone, leading to chronic pain and loss of joint function. Depending on the extent of damage, individuals must undergo surgical treatment, the most extensive being total knee replacement, which over 800,000 Americans undergo each year.
Dr. Melissa Grunlan, professor in the Department of Biomedical Engineering at Texas A&M University, received a grant from the National Institute of Arthritis and Musculoskeletal and Skin Disease, a suborganization of the National Institutes ...
CU researchers analyze prevalence, impact of ethical or religious barriers to providing medical aid in dying
2024-05-31
Recently published research led by the University of Colorado Anschutz Medical Campus examined the prevalence — and impact — of physicians’ ethical or religious barriers to their involvement in medical aid in dying (MAiD), a multi-step process where a physician provides a terminally ill adult with decision-making capacity with a lethal dose of medication to end their life.
The research article, “Conscience-Based Barriers to Medical Aid in Dying: A Survey of Colorado Physicians,” was published this May in the Journal of General Internal Medicine. It shows that 26% of physician ...
Want to be a successful scientist? The McClements family has some tips
2024-05-31
The latest book of prolific author David Julian McClements is a family affair. The Distinguished Professor of Food Science, along with his daughter Isobelle Farrell McClements and nephew Jake McClements, have written “How to be a Successful Scientist: A Guide for Graduate Students, Postdocs, and Professors” (Springer, 2024).
The three authors offer different perspectives as scientists at different stages in their careers. Julian McClements, who has published more than 1,300 scientific articles and numerous books, is the most highly ...
Overcoming barriers to heat pump adoption in cold climates and avoiding the 'energy poverty trap'
2024-05-31
Converting home heating systems from natural gas furnaces to electric heat pumps is seen as a way to address climate change by reducing greenhouse gas emissions.
But a new University of Michigan study of 51 Southeast Michigan households shows that switching to efficient, cold-climate heat pumps would increase annual utility bills by an average of about $1,100.
Home weatherization upgrades, such as adding attic insulation and sealing around doors and windows, could help reduce utility bills and make ...
A new way to see viruses in action
2024-05-31
A new, nano-scale look at how the SARS-CoV-2 virus replicates in cells may offer greater precision in drug development, a Stanford University team reports in Nature Communications. Using advanced microscopy techniques, the researchers produced what might be some of the most crisp images available of the virus’s RNA and replication structures, which they witnessed form spherical shapes around the nucleus of the infected cell.
“We have not seen COVID infecting cells at this high resolution and known what we are looking at before,” said Stanley Qi, ...
Wealthier neighborhoods in Boulder saw lower bee diversity
2024-05-31
Community gardens in higher-income Boulder neighborhoods have fewer varieties of bees than their medium-income counterparts, new University of Colorado Boulder research suggests. Scientists suggest that people in these neighborhoods tend to apply more landscaping practices, such as using fertilizers, which could impact bees’ habitats.
The finding appeared May 22 in the journal Urban Ecosystems.
“Bees are so important for local ecosystems through their pollination services. The landscape would not look the same without our pollinators,” ...
Advancing excellence top priority for new board chair
2024-05-31
At its annual meeting on Thursday, the University of Miami Board of Trustees (BOT) confirmed Manuel “Manny” Kadre as its new chair, Wayne Chaplin and Bill Morrison as new vice chairs, and welcomed a slate of new trustees.
Kadre, chairman and chief executive officer of MBB Auto Group as well as a senior executive and shareholder of a number of beverage, automotive, health care, and real estate companies, first joined the board as a trustee in 2004. He served as a vice chair since June 2021 and more recently as board chair-elect.
“The University has one of the great reputations and brand names anywhere in the world,” ...
Martian meteorites deliver a trove of information on Red Planet’s structure
2024-05-31
Mars has a distinct structure in its mantle and crust with discernible reservoirs, and this is known thanks to meteorites that scientists at Scripps Institution of Oceanography at UC San Diego and colleagues have analyzed on Earth.
Meteorites that formed roughly 1.3 billion years ago and then ejected from Mars have been collected by scientists from sites in Antarctica and Africa in recent decades. Scripps Oceanography geologist James Day and his colleagues report May 31 in the journal Science Advances ...
Can ketones enhance cognitive function and protect brain networks?
2024-05-31
Researchers at the Del Monte Institute for Neuroscience at the University of Rochester have identified mechanisms in the brain’s hippocampal network that are rescued by ketones. These findings build on previous research showing that ketones can alleviate neurological and cognitive affects.
As we age our brain naturally becomes more insulin resistant. This creates a breakdown in communication between neurons, causing symptoms like changes in mood, cognitive decline, and eventually neurodegeneration. Nathan A. Smith, MS, PhD ('13), associate professor of Neuroscience, and fellow researchers studied the mechanisms in the brain that break down when insulin resistance is suddenly ...